IBEX Ltd grants legal chief 9,500 stock units

The award vests in four annual installments beginning September 30, 2027, subject to continued service.

Available on EDGAR 11/03/2026 - 05:38 PM EST Accepted by SEC EDGAR 11/03/2026 - 05:38 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

IBEX Ltd Chief Legal Officer Christina Alice Trofimuk-O'Connor was granted 9,500 restricted stock units on October 30, 2026. Each RSU represents a contingent right to receive one common share. The units vest 25% annually over four years, beginning September 30, 2027, provided she remains in continuous service on each vesting date. IBEX will automatically withhold shares on each vesting date for tax withholding obligations in a non-discretionary transaction. The reported direct position after the transaction was 38,424 common shares.

Insider Trade Summary

Grant/Award: 9,500 shares

Grant/Award 1 txn

Insider Trofimuk-O'Connor Christina Alice

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares F1	9,500	$0.00	$0.00

Holdings After Transaction: Common Shares — 38,424 shares (Direct)

Holdings Before and After: Common Shares, 28,924 to 38,424 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. 25% of the granted RSUs shall vest annually over four years, commencing on September 30, 2027, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date, Issuer will automatically withhold shares to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

Key Figures

Restricted stock units granted: 9,500 RSUs Shares per RSU: 1 common share Annual vesting: 25% +3 more

6 metrics

Restricted stock units granted 9,500 RSUs Granted October 30, 2026

Shares per RSU 1 common share Each RSU represents a contingent right to receive one share

Annual vesting 25% Vests annually over four years, subject to continuous service

Vesting period 4 years Annual vesting begins September 30, 2027

First vesting date September 30, 2027 Vesting commencement date

Direct common shares following transaction 38,424 common shares Reported position after the transaction

Key Terms

restricted stock units, contingent right, tax withholding obligations

3 terms

restricted stock units technical

"granted restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right technical

"represent a contingent right to receive one share"

tax withholding obligations financial

"satisfy the Reporting Person's tax withholding obligations"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did IBEX Chief Legal Officer Christina Alice Trofimuk-O'Connor receive?

Christina Alice Trofimuk-O'Connor received 9,500 restricted stock units on October 30, 2026. Each RSU represents a contingent right to receive one IBEX common share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Trofimuk-O'Connor Christina Alice

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20006

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	10/30/2026		A		9,500(1)	A	$0(1)	38,424	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. 25% of the granted RSUs shall vest annually over four years, commencing on September 30, 2027, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date, Issuer will automatically withhold shares to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)